REQUEST A DEMO
Total
USD $0.00
Search more companies

Grape King Bio Ltd (Taiwan, China)

Main Activities: Food Manufacturing
Full name: Grape King Bio Ltd Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Grape King Inc. was founded on July 26, 1969. Approved by Securities and Futures Commission, Ministry of Finance, the company issued public stocks in December 1982. Grape King Inc. is principally engaged in the manufacture, processing and sale of medicine, health food and drinks. The company's products include con sweet lactic acid bacteria, ganoderma lucidum, antrodia camphorata, agaricus blazei, cordyceps sinensis and ganoderma lucidum, coriolus versicolor and hercium erinaceum. During 2009, the company obtained approximately 83.10% of its total revenue from its health food and drinks, respectively. The company distributes its products within Taiwan's domestic markets.

Headquarters
No.402, Sec. 2, Jinling Rd, Pingzhen Dist
Taoyuan City; Taoyuan City;

Contact Details: Purchase the Grape King Bio Ltd report to view the information.

Website: http://www.grapeking.com.tw

Basic Information
Total Employees:
Purchase the Grape King Bio Ltd report to view the information.
Outstanding Shares:
Purchase the Grape King Bio Ltd report to view the information.
Financial Auditors:
Purchase the Grape King Bio Ltd report to view the information.
Incorporation Date:
April 01, 1971
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
4.4%
Purchase this report to view the information.
1.99%
Subsidiaries
Grape King International Investment Inc. (United Kingdom)
100%
溢昭股份有限公司
100%
葡眾企業股份有限公司
60%
Company Performance
Financial values in the chart are available after Grape King Bio Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
7.67%
Total operating revenue
7.52%
Operating profit (EBIT)
3.33%
EBITDA
4.4%
Net Profit (Loss) for the Period
3.99%
Total assets
2.31%
Total equity
5.26%
Operating Profit Margin (ROS)
-0.95%
Net Profit Margin
-0.67%
Return on Equity (ROE)
-0.16%
Debt to Equity Ratio
-0.37%
Quick Ratio
0.03%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?